Lamotrigine Micro Pellets MUPS
ILamotrigine, marketed in the US as Lamictal by GlaxoSmithKline, is ananticonvulsant drug used in the treatment of epilepsy and bipolar disorder.
It is also used as an adjunct in treating depression, though this is considered off-label usage. For epilepsy, it is used to treat partial seizures, primary and secondary tonic-clonic seizures, and seizures associated with Lennox-Gastaut syndrome.
Like many other anticonvulsant medications, Lamotrigine also seems to act as an effective mood stabilizer, and in fact has been the only U.S.
Food and Drug Administration (FDA)-approved drug for this purpose since lithium, a drug approved almost 30 years earlier. It is approved for the maintenance treatment of bipolar type I.
Chemically unrelated to other anticonvulsants (due to lamotrigine's being a phenyltriazine), lamotrigine has relatively few side-effects and does not require blood monitoring in monotherapy.
Lamotrigine is generally accepted to be a member of the sodium channel blocking class of antiepileptic drugs, but it could have additional actions inasmuch as it has a broader spectrum of action than other sodium channel antiepileptic drugs such as phenytoin and carbamazepine and is effective in the treatment of the depressed phase of bipolar disorder, whereas other sodium channel blocking antiepileptic drugs are not.
In addition, lamotrigine shares few side-effects with other, unrelated anticonvulsants known to inhibit sodium channels), which further emphasizes its unique properties. Lamotrigine is inactivated by hepatic glucuronidation.
Lamotrigine IR Micro Pellets - Multiple Unit Particle System (MUPS)
Lamotrigine Micro Granules - Multiple Unit Particle System (MUPS)